EQS-Adhoc: Limes Schlosskliniken AG: LIMES Schlosskliniken expands Management Board
|
EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Personnel/Personnel DGAP-Adhoc: Limes Schlosskliniken AG:
Cologne, December 18, 2023. At its meeting today, the Supervisory Board of LIMES Schlosskliniken AG appointed Dr. Brolund-Spaether (47) to the Management Board with effect from 01.01.2024. Dr. Brolund-Spaether has been working for LIMES Schlosskliniken as Chief Medical Officer since 2019 and Medical Director since 2023. Dr. Brolund-Spaether will be responsible for the medical-therapeutic segment of the LIMES Group. With the expansion of the Management Board, the Supervisory Board has created the personnel requirements for the planned further strong growth of the LIMES group.
Brief profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to subsidies and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de. Your contact person: End of Inside Information
18-Dec-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
| Kaiser-Wilhelm-Ring 26 | |
| 50672 Köln | |
| Germany | |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1799407 |
| End of Announcement | EQS News Service |
|
|
1799407 18-Dec-2023 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 7,43 | 8,18 | 11,02 | 23,44 | 28,81 | 37,17 | 44,00 | |
| EBITDA1,2 | -0,13 | 0,26 | 0,84 | 6,02 | 8,65 | 7,67 | 9,80 | |
| EBITDA-Margin3 | -1,75 | 3,18 | 7,62 | 25,68 | 30,02 | 20,64 | 22,27 | |
| EBIT1,4 | -0,93 | -0,54 | -0,43 | 4,53 | 6,00 | 5,03 | 7,00 | |
| EBIT-Margin5 | -12,52 | -6,60 | -3,90 | 19,33 | 20,83 | 13,53 | 15,91 | |
| Net Profit (Loss)1 | -1,46 | -0,83 | -0,69 | 4,11 | 4,86 | 3,91 | 4,60 | |
| Net-Margin6 | -19,65 | -10,15 | -6,26 | 17,53 | 16,87 | 10,52 | 10,46 | |
| Cashflow1,7 | -0,66 | 0,17 | 0,76 | 4,77 | 8,04 | 6,29 | 0,00 | |
| Earnings per share8 | -5,78 | -2,81 | -2,37 | 13,45 | 14,34 | 11,58 | 14,10 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: B-S-H Collegen
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Limes Schlosskliniken | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0JDBC | DE000A0JDBC7 | AG | 94,99 Mio € | 12.10.2018 | Kaufen | 9F28WWVR+CQ |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 19,17 | 21,28 | 0,90 | 69,01 | 6,28 | 15,10 | 2,56 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 06.06.2025 | 03.09.2024 | 16.05.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -6,32% | -7,77% | +14,08% | +14,08% | +208,57% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
